Impact Partnership Wealth, LLC Amgen Inc Transaction History

Impact Partnership Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $28,231 - $34,078	-105 Reduced 92.11%	9 $2.6 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $702,152 - $792,111	-2,746 Reduced 96.01%	114 $33 Million
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $589,043 - $731,313	2,694 Added 1622.89%	2,860 $769 Million
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $35,568 - $42,059	166 New	166 $36.9 Million

3,073

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Impact Partnership Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Impact Partnership Wealth, LLC with notifications on news.